Treatment News : Gold Drug Shows HIV Eradication Potential

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

April 21, 2011

Gold Drug Shows HIV Eradication Potential

Using a compound containing gold to treat six monkeys infected with an HIV-like virus, a team of researchers has been able to shrink the reservoir of virus-infected CD4 cells impervious to modern-day antiretroviral (ARV) drugs. These early stage results, to be published in a forthcoming issue of AIDS, contribute to a growing body of research exploring the possibility of curing HIV, this time using a drug already approved for the treatment of rheumatoid arthritis: Ridaura (auranofin).

Current antiretroviral (ARV) therapy is quite potent. When it works well, it completely shuts down HIV reproduction. Unfortunately, a small reservoir of long-lived HIV-infected cells remains in the body, and when people stop taking their HIV medication, the virus quickly reseeds newly produced CD4 cells and resumes replication.

Traditional ARVs can’t target HIV genetic material (HIV DNA) inside this reservoir of infected cells, notably long-lived “memory” CD4 cells. This is because the cells are inactive; most ARVs only work in cells that are actively reproducing. Researchers are now exploring compounds that wake up these resting cells to help purge their HIV DNA payload or, more controversially, that kill the cells harboring dormant virus.

The rheumatoid arthritis drug Ridaura falls into the second category. According to the paper published by Andrea Savarino, MD, of the Istituto Superiore di Sanità in Rome and his colleagues, Ridaura works by killing off memory CD4 cells while also shortening the lifespan of new CD4 cells produced by the immune system. In effect, Ridaura shows HIV eradication potential on two levels: It can help wipe out the existing reservoir while at the same time prevent new long-lived reservoirs from developing.

To explore Ridaura’s potential, Savarino’s group conducted a study involving six macaques infected with simian immunodeficiency virus (SIV), HIV’s primate equivalent. After maintaining undetectable SIV levels in the macaques for at least eight weeks using a typical ARV regimen, the researchers added twice-daily Ridaura treatment.

According to the researchers’ report, the addition of Ridaura significantly shorted both the lifespan and size of the long-lived CD4 cells. What’s more, there was no significant effect on the size of the new CD4 cell population and the monkeys’ CD4 counts remained stable throughout treatment. Marked reductions in SIV DNA levels were also documented.

When ARV therapy was stopped in the six monkeys, SIV viral loads rebounded, but to levels that were significantly lower than those seen before ARV treatment was initiated. Conversely, in six monkeys who underwent therapy with ARVs alone, viral loads rebounded to pre-treatment levels in less than two weeks.

“Our [Ridaura-treated] monkeys showed, upon suspension of all therapies, an improved capacity to keep the infection under control; one of them maintained a low viral load and high CD4 counts for one year,” Savarino is quoted as saying in a press release.

The researchers have decided to wait before moving Ridaura into trials involving people living with HIV. “We prefer not to involve people in a trial of the drug immediately,” said Enrico Garaci, MD, president of the Italian Institute of Health, and coauthor of the study. “That’s because in this phase the trial could only be a proof-of-concept study, and we have already this proof in monkeys. We prefer to put all our effort in the intensification of the attack on the virus reservoir in monkeys by using a combined approach.

“This will also allow,” he added, “a more thorough evaluation of the safety of the approach.”

The authors also caution against using Ridaura outside of clinical trial settings. “[T]he side effects of this approach in the presence of HIV are as yet largely unexplored,” Savarino notes. “I strongly recommend that people living with HIV/AIDS do not buy the drug from uncontrolled sources such as eBay and start self-treatment outside highly medicalized settings.”

Search: gold, auranofin, Ridaura, eradication, cure, reservoir


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


  comments 16 - 19 (of 19 total)     << < previous

Namnibor, Columbus, 2011-04-28 22:51:41
Research of 'any kind' can give hope however, KNOWING Human behavior, by the added caviat of warning people NOT to go out and purchase the drug on ebay was grossly irresponsible reporting and perhaps if you proofed it in the eyes of perhaps a LEGAL Dept. of say, THIS RX Mfr.; when the people, that you KNOW WILL NOW go out and DO the VERY thing you basically gave them the razor blades and instructions, with a note saying "you shouldn't"...best to responsibly report than ignorantly for Ego and Id.

Don, , 2011-04-28 12:40:26
I still think and strongly believe the Government has had the cure for HIV Aids for Many Years, they created this horrible disease as a form of population control. But on another note... about time they have a significant breakthrough! Freddie would be happy!

rebbecca, , 2011-04-28 09:16:55
this is a wonderful step in dealing with hiv/aids

Steve, Morristown, 2011-04-27 17:05:12
I wonder why they tried Ridaura in the first place, which leads me to wonder if the drug or combo that accomplishes this will be found by accident. The good news is that this kills all of the cells harboring hiv "memory cells," thereby killing ALL of the hiv cells without needing to "wake them up." The bad news is the article says "it shows hiv eradication potential," which is NOT the same as complete eradication. I wish this team and all others working towards the same goal every success!

comments 16 - 19 (of 19 total)     << < previous


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    acousticmat
    Oakland
    California


    oceanblue65
    louisiana
    Louisiana


    hollywoodvers1
    Los Angeles
    California


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.